This study looks at how well a new blood test works to find early lung cancer in people aged 50 to 80. Participants have had a special type of lung scan, called a low-dose CT (LDCT), showing possible lung cancer signs. The study will last about 2 years, with patients being part of it for at least 12 months. No extra doctor visits are needed as part of the study; instead, the study uses information from regular doctor visits and medical records. To join, participants must not have had lung cancer before and should not have other recent cancers or serious infections.
- Duration: Participation involves a blood test and lasts at least 12 months.
- Visits: No extra visits are required beyond your regular doctor appointments.
- Eligibility: Must be aged 50-80 and have specific results from a recent lung scan.
How understandable was the trial content above?
Hard to understand
Easy to understand